Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women

J. A. Cook, D. Grey, J. Burke-Miller, M. H. Cohen, Kathryn Anastos, M. Gandhi, J. Richardson, T. Wilson, M. Young

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

This study examines the effects of treated and untreated depressive symptoms on the likelihood of utilization of highly active antiretroviral therapy (HAART) among a multi-site cohort of HIV-infected women who screened positive for probable depression. Data were collected biannually from 1996 through 2002 in a prospective cohort study. Random-effects regression analysis was used to estimate the longitudinal effects of mental health treatment on the probability of HAART utilization, controlling for clinical indicators (CD4 count, viral load), demographic features (race/ethnicity, income), and behavioural factors (recent crack, cocaine, or heroin use). Use of antidepressants plus mental health therapy, or use of mental health therapy alone significantly increased the probability of HAART utilization, compared to receiving no depression treatment. Use of antidepressants alone did not differ significantly from receiving no depression treatment. African American women and those who used crack, cocaine, or heroin also were less likely to use HAART. These findings suggest that efforts to enhance depressed women's access to psychopharmacologic treatment and therapy may increase their use of the most effective HIV therapies.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
Volume18
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Highly Active Antiretroviral Therapy
HIV
Depression
Crack Cocaine
Mental Health
utilization
mental health
Heroin
Therapeutics
Antidepressive Agents
CD4 Lymphocyte Count
Viral Load
African Americans
regression analysis
Cohort Studies
ethnicity
Regression Analysis
Demography
Prospective Studies
income

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)
  • Social Sciences (miscellaneous)

Cite this

Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. / Cook, J. A.; Grey, D.; Burke-Miller, J.; Cohen, M. H.; Anastos, Kathryn; Gandhi, M.; Richardson, J.; Wilson, T.; Young, M.

In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 18, No. 2, 02.2006, p. 93-100.

Research output: Contribution to journalArticle

Cook, J. A. ; Grey, D. ; Burke-Miller, J. ; Cohen, M. H. ; Anastos, Kathryn ; Gandhi, M. ; Richardson, J. ; Wilson, T. ; Young, M. / Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2006 ; Vol. 18, No. 2. pp. 93-100.
@article{c6b3e432f4b74acaa90853069f3e0248,
title = "Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women",
abstract = "This study examines the effects of treated and untreated depressive symptoms on the likelihood of utilization of highly active antiretroviral therapy (HAART) among a multi-site cohort of HIV-infected women who screened positive for probable depression. Data were collected biannually from 1996 through 2002 in a prospective cohort study. Random-effects regression analysis was used to estimate the longitudinal effects of mental health treatment on the probability of HAART utilization, controlling for clinical indicators (CD4 count, viral load), demographic features (race/ethnicity, income), and behavioural factors (recent crack, cocaine, or heroin use). Use of antidepressants plus mental health therapy, or use of mental health therapy alone significantly increased the probability of HAART utilization, compared to receiving no depression treatment. Use of antidepressants alone did not differ significantly from receiving no depression treatment. African American women and those who used crack, cocaine, or heroin also were less likely to use HAART. These findings suggest that efforts to enhance depressed women's access to psychopharmacologic treatment and therapy may increase their use of the most effective HIV therapies.",
author = "Cook, {J. A.} and D. Grey and J. Burke-Miller and Cohen, {M. H.} and Kathryn Anastos and M. Gandhi and J. Richardson and T. Wilson and M. Young",
year = "2006",
month = "2",
doi = "10.1080/09540120500159284",
language = "English (US)",
volume = "18",
pages = "93--100",
journal = "AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV",
issn = "0954-0121",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women

AU - Cook, J. A.

AU - Grey, D.

AU - Burke-Miller, J.

AU - Cohen, M. H.

AU - Anastos, Kathryn

AU - Gandhi, M.

AU - Richardson, J.

AU - Wilson, T.

AU - Young, M.

PY - 2006/2

Y1 - 2006/2

N2 - This study examines the effects of treated and untreated depressive symptoms on the likelihood of utilization of highly active antiretroviral therapy (HAART) among a multi-site cohort of HIV-infected women who screened positive for probable depression. Data were collected biannually from 1996 through 2002 in a prospective cohort study. Random-effects regression analysis was used to estimate the longitudinal effects of mental health treatment on the probability of HAART utilization, controlling for clinical indicators (CD4 count, viral load), demographic features (race/ethnicity, income), and behavioural factors (recent crack, cocaine, or heroin use). Use of antidepressants plus mental health therapy, or use of mental health therapy alone significantly increased the probability of HAART utilization, compared to receiving no depression treatment. Use of antidepressants alone did not differ significantly from receiving no depression treatment. African American women and those who used crack, cocaine, or heroin also were less likely to use HAART. These findings suggest that efforts to enhance depressed women's access to psychopharmacologic treatment and therapy may increase their use of the most effective HIV therapies.

AB - This study examines the effects of treated and untreated depressive symptoms on the likelihood of utilization of highly active antiretroviral therapy (HAART) among a multi-site cohort of HIV-infected women who screened positive for probable depression. Data were collected biannually from 1996 through 2002 in a prospective cohort study. Random-effects regression analysis was used to estimate the longitudinal effects of mental health treatment on the probability of HAART utilization, controlling for clinical indicators (CD4 count, viral load), demographic features (race/ethnicity, income), and behavioural factors (recent crack, cocaine, or heroin use). Use of antidepressants plus mental health therapy, or use of mental health therapy alone significantly increased the probability of HAART utilization, compared to receiving no depression treatment. Use of antidepressants alone did not differ significantly from receiving no depression treatment. African American women and those who used crack, cocaine, or heroin also were less likely to use HAART. These findings suggest that efforts to enhance depressed women's access to psychopharmacologic treatment and therapy may increase their use of the most effective HIV therapies.

UR - http://www.scopus.com/inward/record.url?scp=28744459555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28744459555&partnerID=8YFLogxK

U2 - 10.1080/09540120500159284

DO - 10.1080/09540120500159284

M3 - Article

VL - 18

SP - 93

EP - 100

JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

SN - 0954-0121

IS - 2

ER -